.@AlexBrill_DC and @ben_ippolito: A good place to start is the FDA’s 2018 Biosimilar Action Plan, which encourages… https://t.co/Ni44d1LUpA
.@AlexBrill_DC and @ben_ippolito: A good place to start is the FDA’s 2018 Biosimilar Action Plan, which encourages… https://t.co/Ni44d1LUpA